209 related articles for article (PubMed ID: 7223659)
21. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
Parker JO; Farrell B
Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
[TBL] [Abstract][Full Text] [Related]
22. Nadolol compared to propranolol for treating chronic stable angina pectoris.
Miller LA; Crawford MH; O'Rourke RA
Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
[TBL] [Abstract][Full Text] [Related]
23. Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectoris.
Bassan MM; Weiler-Ravell D
Am Heart J; 1983 Feb; 105(2):234-8. PubMed ID: 6823805
[TBL] [Abstract][Full Text] [Related]
24. Chronic stable angina: comparison of verapamil and propranolol.
Southall E; Nutt NR; Thomas RD
J Int Med Res; 1982; 10(5):361-6. PubMed ID: 6754509
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
[TBL] [Abstract][Full Text] [Related]
26. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
Moppert J; Degen PH; Racine-Poon A
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
[TBL] [Abstract][Full Text] [Related]
27. Studies with long acting propranolol.
Shanks RG
Postgrad Med J; 1984; 60 Suppl 2():61-8. PubMed ID: 6463010
[No Abstract] [Full Text] [Related]
28. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.
Leahey WJ; Neill JD; Varma MP; Shanks RG
Eur J Clin Pharmacol; 1980 Jun; 17(6):419-24. PubMed ID: 7398733
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
30. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
31. Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.
Halkin H; Vered I; Saginer A; Rabinowitz B
Eur J Clin Pharmacol; 1979; 16(6):387-91. PubMed ID: 393520
[No Abstract] [Full Text] [Related]
32. Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
Talbot S
Cardiology; 1976; 61(4):254-66. PubMed ID: 13931
[TBL] [Abstract][Full Text] [Related]
33. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
Subramanian VB; Bowles MJ; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
[TBL] [Abstract][Full Text] [Related]
34. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.
Detry JM; Sellier P; Pennaforte S; Cokkinos D; Dargie H; Mathes P
Br J Clin Pharmacol; 1994 Mar; 37(3):279-88. PubMed ID: 8198938
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
Furberg B; Dahlqvist A; Raak A; Wrege U
Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
[TBL] [Abstract][Full Text] [Related]
36. Comparison of adrenergic beta-blocking drugs in angina pectoris.
Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, placebo-controlled trial of propranolol given once, twice and four times daily in stable angina pectoris: a multicenter study using serial exercise testing.
Beller GA; Bittar N; Coelho JB; Craddock GB; Ezekowitz MD; Murray GC; Steen SN; Waksman JA
Am J Cardiol; 1984 Jul; 54(1):37-42. PubMed ID: 6377865
[TBL] [Abstract][Full Text] [Related]
38. Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard BN
Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
[No Abstract] [Full Text] [Related]
39. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
[TBL] [Abstract][Full Text] [Related]
40. Experience with a slow-release formulation of oxprenolol.
Waal-Manning HJ; Spears GF
N Z Med J; 1978 Apr; 87(609):245-6. PubMed ID: 275650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]